Infinity Pharmaceuticals Price Prediction

INFIDelisted Stock  USD 0.04  0.03  42.86%   
As of 25th of April 2024, the value of RSI of Infinity Pharmaceuticals' share price is approaching 38. This usually indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Infinity Pharmaceuticals, making its price go up or down.

Oversold Vs Overbought

38

 
Oversold
 
Overbought
Infinity Pharmaceuticals stock price prediction is an act of determining the future value of Infinity Pharmaceuticals shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Infinity Pharmaceuticals' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Infinity Pharmaceuticals and does not consider all of the tangible or intangible factors available from Infinity Pharmaceuticals' fundamental data. We analyze noise-free headlines and recent hype associated with Infinity Pharmaceuticals, which may create opportunities for some arbitrage if properly timed.
It is a matter of debate whether delisted stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Infinity Pharmaceuticals based on different types of headlines from major news networks to social media. The Infinity stock price prediction module provides an analysis of price elasticity to changes in media outlook on Infinity Pharmaceuticals over a specific investment horizon. Using Infinity Pharmaceuticals hype-based prediction, you can estimate the value of Infinity Pharmaceuticals from the perspective of Infinity Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Infinity Pharmaceuticals. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Infinity Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Infinity because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Infinity Pharmaceuticals after-hype prediction price

    
  USD 0.04  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Infinity Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.040.040.04
Details
Naive
Forecast
LowNextHigh
0.020.020.02
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.020.070.11
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Infinity Pharmaceuticals. Your research has to be compared to or analyzed against Infinity Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Infinity Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Infinity Pharmaceuticals.

Infinity Pharmaceuticals After-Hype Price Prediction Density Analysis

As far as predicting the price of Infinity Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Infinity Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Infinity Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Infinity Pharmaceuticals Estimiated After-Hype Price Volatility

In the context of predicting Infinity Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Infinity Pharmaceuticals' historical news coverage. Infinity Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.04 and 0.04, respectively. We have considered Infinity Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.04
0.04
After-hype Price
0.04
Upside
Infinity Pharmaceuticals is very steady at this time. Analysis and calculation of next after-hype price of Infinity Pharmaceuticals is based on 3 months time horizon.

Infinity Pharmaceuticals Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Infinity Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Infinity Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Infinity Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
12 Events / Month
18 Events / Month
In about 12 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.04
0.04
0.00 
0.00  
Notes

Infinity Pharmaceuticals Hype Timeline

Infinity Pharmaceuticals is currently traded for 0.04. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Infinity is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Infinity Pharmaceuticals is about 0.0%, with the expected price after the next announcement by competition of 0.04. About 23.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.45. Infinity Pharmaceuticals had not issued any dividends in recent years. The entity had 1:4 split on the 13th of September 2006. Given the investment horizon of 90 days the next forecasted press release will be in about 12 days.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census.

Infinity Pharmaceuticals Related Hype Analysis

Having access to credible news sources related to Infinity Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Infinity Pharmaceuticals' future price movements. Getting to know how Infinity Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Infinity Pharmaceuticals may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
NXTCNextCure 0.31 5 per month 4.97  0.08  8.13 (7.93) 32.17 
CMRXChimerix 0.01 7 per month 3.31 (0.01) 4.95 (5.21) 25.63 
ELDNEledon Pharmaceuticals 0.22 5 per month 4.16  0.04  6.93 (6.53) 33.28 
KRBPKiromic BiopharmaInc(0.11)2 per month 0.00 (0.21) 6.78 (8.23) 24.57 
NLTXNeoleukin Therapeutics(0.12)2 per month 0.00 (0.04) 6.67 (5.67) 15.97 
CTMXCytomX Therapeutics 0.07 10 per month 3.86  0.01  8.16 (5.80) 50.71 
ASMBAssembly Biosciences 0.38 7 per month 3.30  0.10  6.20 (4.63) 19.82 
TILInstil Bio 0.29 8 per month 0.00 (0.04) 3.34 (3.60) 15.97 
NUVBNuvation Bio(0.39)9 per month 3.91  0.14  16.67 (6.50) 46.16 
GBIOGeneration BioCo 0.25 7 per month 4.71  0.17  10.00 (7.51) 34.39 
KRONKronos BioInc 0.04 10 per month 0.00 (0.02) 7.50 (6.31) 28.53 
ERASErasca Inc(0.36)8 per month 3.74  0.03  7.10 (6.31) 25.03 
CCCCC4 TherapeuticsInc(1.17)9 per month 4.39  0.05  11.94 (7.09) 32.75 
EWTXEdgewise Therapeutics 0.06 9 per month 3.17  0.01  5.79 (5.19) 18.27 
LYRALyra TherapeuticsInc(0.21)7 per month 3.73 (0) 6.77 (5.57) 19.97 
TRVITrevi Therapeutics 0.06 28 per month 3.25  0.21  12.26 (6.58) 25.57 
SQZSqz BiotechnologiesCo 0.00 1 per month 0.00 (0.15) 18.18 (23.08) 103.87 
TARAProtara Therapeutics 0.05 6 per month 4.24  0.12  15.01 (6.12) 34.29 
TCONTRACON Pharmaceuticals 8.73 9 per month 12.32  0.01  19.59 (23.73) 108.97 
ADTXAditxt Inc(0.01)8 per month 0.00 (0.17) 5.97 (8.31) 24.80 
NRBONeurobo Pharmaceuticals(0.64)9 per month 5.35  0.02  9.12 (10.81) 81.23 
DRMADermata Therapeutics(0.01)4 per month 0.00 (0.03) 9.38 (6.12) 39.87 
UNCYUnicycive Therapeutics(0.07)8 per month 4.23  0.07  12.33 (6.56) 29.80 
REVBRevelation Biosciences(0.26)9 per month 0.00 (0.13) 13.33 (18.75) 95.47 

Infinity Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Infinity price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Infinity using various technical indicators. When you analyze Infinity charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Infinity Pharmaceuticals Predictive Indicators

The successful prediction of Infinity Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Infinity Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Infinity Pharmaceuticals based on analysis of Infinity Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Infinity Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Infinity Pharmaceuticals's related companies.

Story Coverage note for Infinity Pharmaceuticals

The number of cover stories for Infinity Pharmaceuticals depends on current market conditions and Infinity Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Infinity Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Infinity Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Infinity Pharmaceuticals Short Properties

Infinity Pharmaceuticals' future price predictability will typically decrease when Infinity Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Infinity Pharmaceuticals often depends not only on the future outlook of the potential Infinity Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Infinity Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding89.2 M
Cash And Short Term Investments38.3 M
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census.
Note that the Infinity Pharmaceuticals information on this page should be used as a complementary analysis to other Infinity Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Consideration for investing in Infinity Stock

If you are still planning to invest in Infinity Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Infinity Pharmaceuticals' history and understand the potential risks before investing.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital